2015 Annual General Meeting of Galenica Ltd.
Thursday, 7 May 2015, ↓ directly to download
87th Annual General Meeting of Galenica Ltd.: Shareholders approve all proposals submitted by the Board of Directors
For the first time, shareholders had a prospective vote on the maximum possible total remuneration of the Board of Directors, the Executive Chairman and the Corporate Executive Committee for 2016. Two new members were also proposed for election to the Board of Directors: Marc de Garidel, Chairman of the Board of Directors and CEO of Ipsen, France, as well as Romeo Cerutti, member of the Executive Board and General Counsel of Credit Suisse Group Ltd., Switzerland. The shareholders approved all the proposals put forward by the Board of Directors.
The 87th Annual General Meeting of Galenica Ltd. in Bern was attended by 370 shareholders, representing a total of 58% of the registered voting hares of Galenica Ltd.
The shareholders voted in favour of the proposals put forward by the Board of Directors on all items on the agenda: The Annual General Meeting approved the Annual Report and the 2014 Annual Financial Statements of Galenica Ltd. as well as the Consolidated Financial Statements of the Galenica Group for 2014 and discharged the members of the Board of Directors and the Corporate Executive Committee from liability for their activities in 2014.
The Remuneration Report was submitted to shareholders for a consultative vote for the eighth time. The 2014 Remuneration Report was approved by more than 91% of the shareholders.
Also approved was the dividend of CHF 15.00 (+7.1%, prior year: CHF 14.00) proposed by the Board of Directors, which will be paid to shareholders on 15 May 2015.
Galenica is a diversified Group active throughout the healthcare market which, among other activities, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks. With its two Business units Vifor Pharma and Galenica Santé, the Galenica Group enjoys a leading position in all its core business activities. A large part of the Group’s income is generated by international operations. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALN, security number 1,553,646).
Tuesday, 1 December 2015
Wednesday, 30 September 2015
Tuesday, 11 August 2015
Tuesday, 11 August 2015
Head of Corporate Communications
Head Investor Relations